Study shows promise for detecting mental health problems using smartphone app

smartphone payment
A recent study using Mindstrong Health’s smartphone app showed promise in predicting when mental health issues occur and why they happen. (Image: ipopba/iStock/Getty Images Plus/Getty Images)

A recent study using Mindstrong Health’s app that analyzes smartphone habits showed promise in predicting when mental health issues occur and why they happen.

The study, published in the journal NPJ Digital Medicine, used the smartphone app to collect user activity in 27 volunteers that helped healthcare providers measure a user’s daily habits and detect when those habits deviate. Called digital biomarkers, those habits, when linked with other social and environmental data, provided the information needed to predict mental health issues.

The Mindstrong app captures data on a user’s smartphone activity, including swipes, taps and keystroke events, which was used to identify more than 1,000 distinct digital biomarkers over a 7-day period.


Share your opinion. Take our five minute survey.

How do you select the most suitable advanced dosage forms for new molecules in your development pipelines? Share your insights in this 5-minute survey. The first 50 qualified respondents will receive a $5 Amazon gift card.

“We believe that digital biomarkers are the foundation for measurement-based mental health care, for which there is a massive unmet patient need,” Dr. Paul Dagum, the study’s author and chief executive of Mindstrong, said in a statement. “To provide better mental health care, we need better ways to measure cognitive function and brain health that are quantitative, reproducible, continuous and objective.”

Mindstrong’s technology digests patterns of interaction by tracking which words are used or where and when calls are made and then turns them into objective measures of brain function. The passive app allows for day-to-day monitoring of patients with neuropsychological and neurodegenerative conditions without being intrusive.

Suggested Articles

Boston Scientific’s deep brain stimulation implant for treating Parkinson’s disease has been approved by the FDA as safe to use within an MRI.

The FDA approved a new device for people suffering from advanced heart failure who are not able to receive treatment from other devices.

Alcon has announced plans to launch its daily disposable contact lens in the U.S. made from a new material.